Abstract
Empiric anti-inflammatory therapy for acute and recurrent pericarditis is warranted for viral and idiopathic cases that represent most cases of pericarditis in developed countries. For specific uncomplicated etiologies, such as systemic autoimmune diseases and postpericardiotomy syndromes, the same drugs are also indicated. Aspirin and non-steroidal anti-inflammatory drugs (NSAID) are mainstay of therapy with the possible adjunct of colchicine, especially for recurrences. Corticosteroids are a second choice for difficult cases requiring multi-drug therapies and specific medical conditions (i.e., specific cases with systemic autoimmune diseases, postpericardiotomy syndrome, and pregnancy). Medical therapy of pericarditis should be individualized as much as possible providing the attack dose every 8 h to ensure full daily control of symptoms and till remission and C-reactive protein normalization, and then tapering should be considered. The present paper will review current evidence for the treatment of acute and recurrent pericarditis with aspirin, NSAID, corticosteroids, and colchicine.
Similar content being viewed by others
References
Little WC, Freeman GL (2006) Pericardial disease. Circulation 113:1622–1632
Imazio M, Spodick DH, Brucato A et al (2010) Controversial issues in the management of pericardial diseases. Circulation 121:916–928
Imazio M, Trinchero R, Shabetai R (2007) Pathogenesis, management, and prevention of recurrent pericarditis. J Cardiovasc Med (Hagerstown) 8(6):404–410
Imazio M, Brucato A, Trinchero R, Adler Y (2009) Diagnosis and management of pericardial diseases. Nat Rev Cardiol 6:743–751
Maisch B, Seferovic PM, Ristic AD et al (2004) Task force on the diagnosis and management of pericardial diseases of the european society of cardiology. Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 25:587–610
Imazio M, Spodick DH, Brucato A et al (2010) Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract 64:1384–1392
Maisch B, Ristic AD (2002) The classification od pericardial disease in the age of modern medicine. Curr Cardiol Rep 4:13–21
Levy PY, Fournier PE, Charrel R, Metras D, Habib G, Raoult D (2006) Molecular analysis of pericardial fluid: a 7-year experience. Eur Heart J 16:1942–1946
Seferović PM, Ristić AD, Maksimović R, Tatić V, Ostojić M, Kanjuh V (2003) Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation 107:978–983
Lorbar M, Spodick DH (2007) ‘Idiopathic’ pericarditis—the clinician’s challenge [nothing is idiopathic]. Int J Clin Pract 61:138–142
Imazio M, Brucato A, Derosa FG et al (2009) Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 10:217–230
Ntsekhe M, Mayosi BM (2009) Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 6:120–127
Imazio M, Brucato A, Mayosi BM et al (2010) Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown) 11:712–722
Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112:3608–3616
Pankuweit S, Ristić AD, Seferović PM, Maisch B (2005) Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs 5:103–112
Maisch B, Ristic A, Pankuweit S (2010) Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis 53:157–163
Lestuzzi C (2010) Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol 2:270–279
Imazio M, Brucato A, Maestroni S et al (2011) Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 123:1092–1097
Imazio M, Brucato A, Trinchero R et al (2009) Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther 7:965–975
Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671
Maisch B, Ristic A, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone. The way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23:1503–1508
Frasiolas JA, Cahoon WD (2010) Intrapericardial triamcinolone administration for autoreactive pericarditis. Ann Pharmacother 44:1641–1646
Shabetai R (2005) Recurrent pericarditis. Recent advances and remaining questions. Circulation 112:1921–1923
Imazio M, Brucato A, Trinchero R et al (2009) Colchicine for pericarditis: hype or hope? Eur Heart J 30:532–539
Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R (2005) Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 112(13):2012–2016
Imazio M, Bobbio M, Cecchi E et al (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165:1987–1991
Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH (2011) CORP (COlchicine for Recurrent Pericarditis) investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 155(7):409–414
Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411–419
Cocco G, Chu DC, Pandolfi S (2010) Colchicine in clinical medicine. A guide for internists. Eur J Intern Med 21:503–508
Imazio M, Cecchi E, Ierna S (2007) ICAP investigators. Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationale. J Cardiovasc Med (Hagerstown) 8(8):613–617
Caforio AL, Brucato A, Doria A et al (2010) Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96:779–784
Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S, Marcolongo R (2011) Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 147:477–478
Maisch B, Hufnagel G, Kölsch S, Funck R, Richter A, Rupp H, Herzum M, Pankuweit S (2004) Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29:624–636
Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720–3732
Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi MG, Brucato A (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346
Imazio M, Brucato A, Rampello S et al (2010) Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown) 11:557–562
Conflict of interest
All authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imazio, M., Adler, Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail Rev 18, 355–360 (2013). https://doi.org/10.1007/s10741-012-9328-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-012-9328-9